Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer
- 27 July 2009
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 45 (13), 2239-2248
- https://doi.org/10.1016/j.ejca.2009.06.021
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Elevated expression of Runx2 as a key parameter in the etiology of osteosarcomaMolecular Biology Reports, 2008
- Runx2 Regulates G Protein-coupled Signaling Pathways to Control Growth of Osteoblast ProgenitorsJournal of Biological Chemistry, 2008
- Modulation of Runx2 Activity by Estrogen Receptor-α: Implications for Osteoporosis and Breast CancerEndocrinology, 2008
- Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with boneCancer and Metastasis Reviews, 2006
- Insights Into the Role of Progesterone Receptors in Breast CancerJournal of Clinical Oncology, 2005
- Regulatory Controls for Osteoblast Growth and Differentiation: Role of Runx/Cbfa/AML FactorsCritical Reviews™ in Eukaryotic Gene Expression, 2004
- Runx2 Integrates Estrogen Activity in OsteoblastsJournal of Biological Chemistry, 2003
- Hormonal carcinogenesisCarcinogenesis: Integrative Cancer Research, 2000
- Time- and Dose-Related Interactions between Glucocorticoid and Cyclic Adenosine 3',5'-Monophosphate on CCAAT/Enhancer-Binding Protein-Dependent Insulin-Like Growth Factor I Expression by OsteoblastsEndocrinology, 2000
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991